PressNovember 30, 2022 GOODMIND™ Available for Sale in the United Kingdom and Europe – Exclusive Distribution Agreement Concluded With This Works
PressNovember 30, 2022 Irwin Naturals Leverages Household Brand Status in Effort to be World’s Largest Chain of Psychedelic Mental Health Clinics
PressNovember 30, 2022 Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America
PressNovember 30, 2022 Psyrise Launches the First End-To-End Marketing Platform for Ketamine Clinics, Retreats, and Psychedelic-Assisted Therapists
PressNovember 28, 2022 Field Trip Health & Wellness Ltd. Announces Updated Time for Fiscal Second Quarter 2023 Financial Results and Conference Call
PressNovember 27, 2022 Revive Therapeutics Announces FDA Recommendation for Type C Meeting to Discuss Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
PressNovember 27, 2022 Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial
PressNovember 27, 2022 Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officer
PressNovember 22, 2022 Field Trip Health & Wellness Ltd. Strengthens Leadership Team With Two Executive Appointments, Schedules Fiscal Second Quarter 2023 Conference Call
PressNovember 22, 2022 KAYA HOLDINGS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
PressNovember 22, 2022 Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022
PressNovember 22, 2022 Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction
PressNovember 21, 2022 Core One Labs Prepares for Commercial Production of API-Grade Psilocybin Plans Initial Production Run at GMP Facility in January
PressNovember 21, 2022 Mydecine Innovations Group Files Prospectus Supplement and Announces Closing Under Share Subscription Agreement
